Evidence map›Paper›PMID 37986164›Full record

ArticleMicrobial cell factories2023

Optimization of trans-4-hydroxyproline synthesis pathway by rearrangement center carbon metabolism in Escherichia coli.

Yu Gong, Ruiqi Wang, Ling Ma, Shuo Wang, Changgeng Li, Qingyang Xu

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. EfficientSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yu GongCollege of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, People's Republic of China.
Ruiqi WangCollege of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, People's Republic of China.
Ling MaCollege of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, People's Republic of China.
Shuo WangCollege of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, People's Republic of China.
Changgeng LiCollege of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, People's Republic of China.
Qingyang XuCollege of Biotechnology, Tianjin University of Science & Technology, Tianjin, 300457, People's Republic of China. xuqingyang@tust.edu.cn.
Tianjin University of Science and Technology · CN

Funding

shandong Province Key R & D Plan Project 2021ZDSYS10Tianjin Science and Technology Program 21ZXSYSY00060
6 · The paper itself

Abstract

backgroundtrans-4-Hydroxyproline (T-4-HYP) is a promising intermediate in the synthesis of antibiotic drugs. However, its industrial production remains challenging due to the low production efficiency of T-4-HYP. This study focused on designing the key nodes of anabolic pathway to enhance carbon flux and minimize carbon loss, thereby maximizing the production potential of microbial cell factories.

resultsFirst, a basic strain, HYP-1, was developed by releasing feedback inhibitors and expressing heterologous genes for the production of trans-4-hydroxyproline. Subsequently, the biosynthetic pathway was strengthened while branching pathways were disrupted, resulting in increased metabolic flow of α-ketoglutarate in the Tricarboxylic acid cycle. The introduction of the NOG (non-oxidative glycolysis) pathway rearranged the central carbon metabolism, redirecting glucose towards acetyl-CoA. Furthermore, the supply of NADPH was enhanced to improve the acid production capacity of the strain. Finally, the fermentation process of T-4-HYP was optimized using a continuous feeding method. The rate of sugar supplementation controlled the dissolved oxygen concentrations during fermentation, and Fe

conclusionThis study presents a strategy for establishing a microbial cell factory capable of producing T-4-HYP at high levels, making it suitable for large-scale industrial production. Additionally, this study provides valuable insights into regulating synthesis of other compounds with α-ketoglutaric acid as precursor.

Indexed as

Biosynthetic PathwaysEscherichia coliCarbonCitric Acid CycleHydroxyprolineMetabolic EngineeringProlyl HydroxylasesCarbonHydroxyprolineProlyl HydroxylasesAcetyl-CoAEscherichia coliNADPH supplyNOG pathwaytrans-4-Hydroxyprolineα-Ketoglutarate

Identifiers

PMID37986164
PMCPMC10659092
OpenAlexW4388826921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.